Impact of Diabetes Apps on Blood Glucose Meter Recommendations

Modern Blood Glucose Meter (BGM) devices can often pair with a companion app on a smartphone, which allows patients to easily record and monitor their blood glucose levels over time. This gives the patient, and potentially their doctor, easy to access historical data, insightful charts, and other information that can aid in diabetes management.

MD Analytics conducted a market research study to assess whether Canadian GPs are accepting this technology, and if it plays a role in their recommendation of one BGM over another.

Read More

GPs recognize the importance of BGM apps as they relate to diabetes management. 87% of GPs agree that BGM apps will play an increased role in how patients manage their diabetes. 82% of GPs agree that BGM apps will play an increased role in how they advise patients on how to manage their diabetes.

Among GPs, there is no leader with respect to which BGM app is currently used the most frequently. Most GPs are aware of Contour Diabetes, OneTouch Reveal, and Accu-Chek Connect, and each have been used by 1 in 5 GPs.

BGM apps will impact future meter recommendations. 71% of GPs agree that the presence of a diabetes app will positively impact their likelihood to recommend that BGM to a patient.

See our infographic for a more detailed look at our study with data based on n=118 Canadian GPs.

Past Quick Polls

COVID-19 Impact on Women in Pharma

The COVID-19 crisis changed the way people work across industries including the pharma industry. MD Analytics teamed up with the professional association for women in the pharma industry Women Leaders in Pharma to conduct a study on the impact on of COVID-19 on women who work in the pharma industry.

read more

Pandemic’s Impact on HCPs Practices and Vaccination Campaign Perceptions

The COVID-19 vaccination campaign is underway in Canada. However, the pandemic has significantly altered HCPs’ practices to date. These changes have impacted workloads, patient assessments, and interactions with pharma. A year into the pandemic, a national COVID-19 vaccination campaign is underway. This begs the question, how are Canadian HCPs doing today? What do they foresee moving forward? Our latest short survey presents the current state of HCPs’ practices in Canada and their assessment of the government’s management of COVID-19.

read more

Remote Detailing for Pharma – Physicians’ perspectives

Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.

read more

We are here to answer your questions.

Share This